1. Catalog
  2. 2026 Advanced Addiction Psychopharmacology
2026 Advanced Addiction Psychopharmacology
Create Account
Availability
Registration Required
Expires on Dec 17, 2026
Online Meeting
Oct 17, 2026 12:00 PM - 3:35 PM ET
Oct 18, 2026 12:00 PM - 3:35 PM ET
Cost
Member: $275.00
Non-Member: $325.00
  • Course Overview
  • About this Course
  • Live Q&A Session Schedule
  • Faculty
  • Recommended



Welcome to the Advanced Addiction Psychopharmacology (AAP) Virtual Course, presented by the American Academy of Addiction Psychiatry (AAAP). This intensive, 14-hour online course is designed for physicians and other health care professionals who have a foundation in prescribing medication for patients with substance use disorders, including those with co-occurring psychiatric conditions, but would like a deeper understanding of these pharmacotherapies. The course features nationally recognized faculty experts.

Course Format

This course includes two components:

  • On-Demand Sessions (8 hours): Pre-recorded lectures released approximately one month prior to the live Q&A sessions. Participants are strongly encouraged to view these sessions before attending the live Q&A to get the most out of the discussion, and on-demand content will remain available after the live event for continued learning.
  • Live Q&A Sessions (6 hours): Two days of live, interactive Q&A sessions with expert faculty covering pharmacotherapy across key clinical populations and co-occurring conditions.

Date & Time

Live Session Dates:
Saturday, October 17, 2026: 12:00 PM – 3:35 PM ET
Sunday, October 18, 2026: 12:00 PM – 3:35 PM ET

Continuing Medical Education (CME)

This activity has been designated for a maximum of 14 AMA PRA Category 1 Credits™.

Target Audience

This intensive, 14-hour, online course is designed for physicians and other health care professionals who have a foundation in prescribing medication for patients with substance use disorders, including those with co-occurring psychiatric conditions, but would like a deeper understanding of these pharmacotherapies.

Educational Objectives

Learners who attend this activity will receive a more in-depth educational experience in the pharmacotherapy of substance use disorders and co-occurring conditions, and after participating in this course, learners should be able to:

  • Discuss the pharmacotherapy of bipolar disorder and schizophrenia in patients with co-occurring substance use disorders.
  • List evidence-based options for anti-depressant and anti-anxiety pharmacotherapy when treating patients with co-occurring substance use disorders.
  • Discuss evidence-based pharmacotherapy for treatment of ADHD with co-occurring substance use disorders.
  • Understand how pharmacotherapy of substance use disorders is modified in the face of medical co-morbidities.
  • Discuss evidence-based pharmacotherapy for treatment of PTSD with co-occurring substance use disorders.
  • Discuss evidence-based pharmacotherapy for treatment of insomnia with co-occurring substance use disorders.
  • Discuss evidence-based pharmacotherapy for treatment of substance use disorders in pregnancy.
  • Discuss evidence-based pharmacotherapy for the treatment of substance use disorders in adolescents.

Topics & Faculty

Topic

Faculty

Saturday, October 17, 2026

Pharmacotherapy of Substance Use Disorders in Adolescents

Justine Welsh, MD

Pharmacotherapy: Perinatal Substance Use Disorders

Constance Guille, MD

Pharmacotherapy of Depressive and Anxiety Disorders with Co-Occurring Substance Use Disorders

Edward Nunes, MD

Pharmacotherapy of ADHD with Co-Occurring Substance Use Disorders

Frances Levin, MD

Sunday, October 18, 2026

Pharmacotherapy of Insomnia with Co-Occurring Substance Use Disorders

Christina Brezing, MD

Pharmacotherapy of Post-Traumatic Stress Disorder with Co-Occurring Substance Use Disorders

Ismene Petrakis, MD

Pharmacotherapy of Bipolar Disorder and Schizophrenia with Co-Occurring Substance Use Disorders

John Mariani, MD

Addiction Psychopharmacology of those with Co-Morbid Medical Conditions

Kevin Sevarino, MD, PhD

 

Saturday, October 17th

Presenter Time: 40 minutes each / Breaks: 15 minutes between sessions

12:00 PM-12:05 PM

Welcome and Introduction to the Live Session

John Mariani, MD, and Kevin Sevarino, MD, PhD

 

12:05 PM-12:45 PM

Pharmacotherapy of Substance Use Disorders in Adolescents

Justine Welsh, MD

 

12:45 PM-1:00 PM

Break

 

1:00 PM-1:40 PM

Pharmacotherapy: Perinatal Substance Use Disorders

Constance Guille, MD

 

1:40 PM-1:55 PM

Break

 

1:55 PM-2:35 PM

Pharmacotherapy of Depressive and Anxiety Disorders with Co-Occurring Substance Use Disorders

Edward Nunes, MD

 

2:35 PM-2:50 PM

Break

 

2:50 PM-3:30 PM

Pharmacotherapy of ADHD with Co-Occurring Substance Use Disorders

Frances Levin, MD

 

3:30 PM-3:35 PM

End of the Day Wrap-Up

 

Sunday, October 18th

Presenter Time: 40 minutes each / Breaks: 15 minutes between sessions

12:00 PM-12:05 PM

Welcome and Introduction to the Live Session

John Mariani, MD, and Kevin Sevarino, MD, PhD

 

12:05 PM-12:45 PM

Pharmacotherapy of Insomnia with Co-Occurring Substance Use Disorders
Christina Brezing, MD

 

12:45 PM-1:00 PM

Break

 

1:00 PM-1:40 PM

Pharmacotherapy of Post-Traumatic Stress Disorder with Co-Occurring Substance Use Disorders

Ismene Petrakis, MD

 

1:40 PM-1:55 PM

Break

 

1:55 PM-2:35 PM

Pharmacotherapy of Bipolar Disorder and Schizophrenia with Co-Occurring Substance Use Disorders

John Mariani, MD

 

2:35 PM-2:50 PM

Break

 

2:50 PM-3:30 PM

Addiction Psychopharmacology of those with Co-Morbid Medical Conditions

Kevin Sevarino, MD, PhD

 

3:30 PM-3:35 PM

End of the Day Wrap-Up

 

The 2026 Advanced Addiction Psychopharmacology Course brings together a distinguished faculty of clinicians and researchers leading the field of addiction psychiatry. The roster below introduces the live and on-demand presenters.

Title: Christina A. Brezing, MD - Description: Christina A. Brezing, MD headshot

Christina A. Brezing, MD

Course Co-Director / Live & On-Demand Faculty

Assistant Professor of Psychiatry, Division on Substance Use Disorders, Columbia University Irving Medical Center; Research Scientist, New York State Psychiatric Institute

Title: Constance Guille, MD - Description: Constance Guille, MD headshot

Constance Guille, MD

Live & On-Demand Faculty

Professor, Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, and Director, Women’s Reproductive Behavioral Health Division, Medical University of South Carolina (MUSC)

Title: Frances Levin, MD - Description: Frances Levin, MD headshot

Frances Levin, MD

Live & On-Demand Faculty

Kennedy-Leavy Professor of Psychiatry, Columbia University; Chief, Division on Substance Use Disorders, NYSPI/Columbia University

Title: John J. Mariani, MD - Description: John J. Mariani, MD headshot

John J. Mariani, MD

Live & On-Demand Faculty

Professor of Clinical Psychiatry, Columbia University Vagelos College of Physicians and Surgeons; Director, Substance Treatment and Research Service (STARS), Division on Substance Use Disorders, NYSPI/Columbia University Irving Medical Center

Title: Edward V. Nunes, MD - Description: Edward V. Nunes, MD headshot

Edward V. Nunes, MD

Live & On-Demand Faculty

Professor of Psychiatry, Columbia University Medical Center and New York State Psychiatric Institute (NYSPI); Principal Investigator, Greater New York Node of the NIDA Clinical Trials Network

Title: Ismene L. Petrakis, MD - Description: Ismene L. Petrakis, MD headshot

Ismene L. Petrakis, MD

Live & On-Demand Faculty

Professor of Psychiatry, Yale University School of Medicine; Chief of Psychiatry and Mental Health Services, VA Connecticut Healthcare System

Title: Kevin A. Sevarino, MD, PhD - Description: Kevin A. Sevarino, MD, PhD headshot

Kevin A. Sevarino, MD, PhD

Course Co-Director / Live & On-Demand Faculty

Associate Clinical Professor of Psychiatry, Yale University School of Medicine; Medical Director, American Academy of Addiction Psychiatry (AAAP)

Title: Justine W. Welsh, MD - Description: Justine W. Welsh, MD headshot

Justine W. Welsh, MD

Live & On-Demand Faculty

Associate Professor, Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine; Vice Chair for Child, Adolescent, and Young Adult Programs; Director, Emory Healthcare Addiction Services
 
American Academy of Addiction Psychiatry
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

  
400 Massasoit Avenue
Suite 108
East Providence, RI 02914
cmecpd@aaap.org

Privacy
About
Advocacy
Membership
Fellowship
Education and Resources
Training Events
 
Powered By